Teen boy talks to female provider

Identify: Find At-Risk Youth

Screening is an essential aspect of suicide prevention. Universal screening identifies risk in a broader population that may not have clear risk within a general population of youth. This can be done within certain parameters such as age or setting, but is often broader and not focused on screening individuals with certain risk factors. Targeted screening, however, focuses on youth with some level of risk - such as a presenting behavioral health concern - risk screening occurs within a group that already has an elevated risk due to the nature of their presentation. 

Depending on your setting and capacity, you may consider starting with one approach for screening and expanding your screening as feasible and as needs dictate, knowing that many youth who experience suicidal ideation may not present with a behavioral health concern or see a behavioral health provider. Universal screening in primary care offices, mental health practices, and emergency departments can ensure youth with elevated risk are identified and receive mental health support. Furthermore, it provides an opportunity for education and awareness for youth and families even when screening does not identify risk

A Comprehensive Approach

Additionally, there are regulatory requirements that may dictate screening practices in your setting. The American Academy of Pediatrics (AAP) recommends universal screening for youth ages 12+. For youth ages 8-11, screening is recommended when clinically indicated such as presenting for behavioral problems. AAP does not recommend screening youth under age 8 if warning signs are present. These are also Joint Commission guidelines that require screening over age 12 in emergency and hospital settings.

There are many evidence based screening tools that can assist in implementing a screening protocol. In most settings this is the CSSR, or ASQ. These screening tools are embedded in many electronic health records as well to ease and streamline suicide screening. At times, the PHQ-9, item-9, may be used as a screen for suicide risk. Although the PHQ-9 is a well validated and easy-to-use depression screen, it serves as a poor screener of suicide risk and should be supplemented by the ASQ or CSSRS to provide more high fidelity suicide risk screening in youth.

Once a screening plan has been developed, it is essential to think about Suicide Assessment. The focus of screening is to identify those at risk. The purpose of assessment is to determine the level of risk and clarify the nature of the risk. There are several evidence-based tools to support risk formulation and clinical assessment to support clinical decision making and connecting youth and families to the appropriate level of care. Two commonly used assessment tools include:

The electronic medical record provides many opportunities to integrate risk screening and assessment as well as creating care pathways to track risk and promote communication. Engage also explores the evidence-informed practices that can be implemented to support youth and families during crisis including lethal means safety and collaborative safety planning.

Evidence-based Assessment

Utilizing a standardized suicide risk assessment is essential for informed clinical decision-making and determining the appropriate level of care. A comprehensive assessment goes beyond screening to confirm the presence and severity of suicide risk, identify imminent danger, and evaluate both risk and protective factors. This process helps clinicians understand the context of suicidal thoughts or behaviors, guide individualized treatment planning, and ensure timely interventions that align with the patient’s level of need. Standardized tools, such as the Columbia Suicide Severity Rating Scale (C-SSRS) or SAFE-T, promote consistency across providers, reduce bias, and support documentation that enhances continuity and quality of care.

Risk factors

Risk factors are static and dynamic characteristics or experiences that research has shown to impact suicide risk. Risk factors can support clinical decision making to understand what acute behavior changes or stressors may be present The following tool provides a mnemonic to recall common risk factors and support during a clinical assessment.

IS PATH WARM:

  • Ideation - threatened or communicated

  • Substance abuse - excessive or increased

  • Purposelessness - No reasons for living

  • Anxiety - Agitation/Insomnia

  • Trapped - Feeling there is no way out

  • Hopelessness

  • Withdrawing - From friends, school, society

  • Anger (uncontrolled) - Rage, seeking revenge

  • Recklessness - Risky acts, unthinking

  • Mood changes - dramatic, sudden change

Jacobs, D. G., & Klein-Benheim, M. (2021)

Risk Formulation

Risk formulation provides an opportunity to integrate information from the assessment to conceptualize risk level and again inform treatment planning. A risk formulation explores static and dynamic risk factors as well as protective factors. A risk assessment explores factors that can be modified in an individual’s environment and supports that can be activated to reduce risk. Oftentimes, risk is conceptualized as low, medium, and high with relevant interventions at each risk level to mitigate risk and promote safety. When reflecting on risk, the goal is to ensure safety in the least restrictive environment. 

The model of risk formulation shared here was developed to reflect on the patient’s past, present, and future. The model assists in creating a narrative that includes the patient's current circumstances, how certain behaviors, beliefs, thoughts, actions, have come to be, how they have impacts on the patient’s life. It also explores available resources that can support in maintaining safety as well as acute changes in the future that may impact risk. The model focuses on identifying interventions that can modify risk to support in developing the most appropriate plan for patients with suicidal thoughts. The inclusion of foreseeable changes reflects on what factors to monitor to continue assessing how risk may change in the future. 

circle diagrams for risk formulation model

This image is a three-part overlapping circle diagram showing how clinical data and risk formulation combine to determine overall risk status. On the left, a gray circle labeled Clinical Data lists factors such as strengths and protective factors, acute stressors, psychiatric history, and recent behaviors. In the center, a large overlapping area labeled Risk Formulation combines information from the other sections to assess current and future risk. On the right, a white circle labeled Available Resources includes items such as coping skills, family support, and access to care. Where all areas overlap, a central section labeled Risk Status represents the clinical judgment of immediate and foreseeable risk, guiding care planning and safety decisions.

More Resources

Suicide and Suicide Risk in Adolescents

Liwei HL, Lee J, Rahmandar MH, Sigel EJ. Pediatrics, 2024, 153(1).

DOI: 10.1542/peds.2023-064800.

 

Suicide prevention training: self-perceived competence among primary healthcare professionals

Solin P, Tamminen N, Partonen T. Scandinavian journal of primary health care, 2021, 39(3), 332-338.
doi: 10.1080/02813432.2021.1958462

 

Universal Suicide Screening Is Feasible and Necessary to Reduce Suicide

Goldstein GJ, Boudreaux, ED. Psychiatric Services, 2023, 74(1), 81-83.

DOI: 10.1176/appi.ps.202100625

 

Current Status of Suicide-Focused Assessment and Treatment: An Online Resource for Clinicians

Jacobs DG, Klein-Benheim M. Stop a Suicide, 2023.

https://stopasuicide.org/wp-content/uploads/2023/05/Current-Status-of-Suicide-Focused-Assessment-and-Treatment-May-2023.pdf

 

Reformulating Suicide Risk Formulation: From Prediction to Prevention

Pisani AR, Murrie DC, Silverman MM. Academic Psychiatry, 2016, 40(4), 623–629.

doi: 10.1007/s40596-015-0434-6

 

Ask Suicide-Screening Questions (ASQ): A Brief Instrument for the Pediatric Emergency Department

Horowitz LM, Bridge JA, Teach SJ, Ballard E, Klima J, Rosenstein DL, Pao M. Archives of Pediatrics & Adolescent Medicine, 2012, 166(12), 1170-1176.

DOI: 10.1001/archpediatrics.2012.1276

 

Validation of the Ask Suicide-Screening Questions (ASQ) for adult medical inpatients: A brief tool for all ages

Horowitz LM, Snyder DJ., Boudreaux ED, He JP, Harrington CJ, Cai J, Claassen CA, Salhany JE, Dao T, Chaves JF, Jobes DA, Merikangas KR, Bridge JA, Pao M. Psychosomatics, 2020, 61(6), 713-722.

DOI: 10.1016/j.psym.2020.04.008

 

Validation and feasibility of the Ask Suicide-Screening Questions (ASQ) among pediatric medical/surgical inpatients

Horowitz, LM, Wharff EA, Mournet AM, Ross AM, McBee-Strayer S, He J, Lanzillo E, White E, Bergdoll E, Powell DS, Merikangas KR, Pao M, Bridge JA. Hospital Pediatrics, 2020, 10(9), 750-757.

DOI: 10.1542/hpeds.2020-0087

 

Validation of the Ask Suicide-Screening Questions (ASQ) with youth in outpatient specialty and primary care clinics

Aguinaldo LD, Sullivant S, Lanzillo EC, Ross A, He JP, Bradley-Ewing A, Bridge JA, Horowitz LM, Wharff EA. General Hospital Psychiatry, 2021, 68, 52–58.

DOI: 10.1016/j.genhosppsych.2020.11.006

 

Universal pediatric suicide risk screening in a health care system: 90,000 patient encounters

Roaten K, Horowitz LM, Bridge JA, Goans CR, McKintosh C, Genzel R, Johnson C, & North CS. Journal of the Academy of Consultation-Liaison Psychiatry, (2021), Jul-Aug;62(4), 421-429.

DOI: 10.1016/j.jaclp.2020.12.002

 

The importance of screening preteens for suicide risk in the emergency department

Lanzillo EC, Horowitz LM, Wharff EA, Sheftall AH, Pao M, Bridge JA. Hospital Pediatrics, 2019, 9(4), 305–307.

DOI: 10.1542/hpeds.2018-0154

 

Assessment of selective and universal screening for suicide risk in a pediatric emergency department

DeVylder JE, Ryan TC, Cwik M, Wilson ME, Jay S, Nestadt PS, Goldstein M, Wilcox HC. JAMA Network Open, 2019, 2(10).

DOI: 10.1001/jamanetworkopen.2019.14070

 

Identification of at-risk youth by suicide screening in a pediatric emergency department

Ballard ED, Cwik M, Van Eck K, Goldstein M, Alfes C, Wilson ME, Wilcox HC. Prevention Science, 2017, 18(2), 174-182.

DOI: 10.1007/s11121-016-0717-5